Femasys

NEWS

Pictured: IVF collage/Nicole Bean for BioSpace

Policy

Alabama Ruling, Political Blowback Rattle In Vitro Fertilization Market

A controversial decision by the Alabama Supreme Court temporarily chilled IVF before igniting nationwide pushes to protect access to this type of fertility treatment, leaving drugmakers with questions.

March 12, 2024

5 min read

Neil Versel

IN THE PRESS

Business

Femasys Announces Financial Results for Quarter Ended March 31, 2024 and Provides Corporate Update

May 9, 2024

7 min read

BioMidwest

Femasys Expands Commercial Management Team with Addition of Experienced New HiresTeam to Drive Strategic Initiatives, Launching Efforts at 2024 ACOG Meeting

May 7, 2024

7 min read

Policy

Femasys Announces Financial Results for Year Ended December 31, 2023 and Provides Corporate Update

March 28, 2024

8 min read

Femasys to Participate in Fireside Chat to Discuss the Infertility Treatment Landscape on March 21, 2024

March 13, 2024

5 min read

Policy

Femasys Completes the First In-Office Commercial Procedure with the FDA-Cleared FemaSeed Infertility Solution

March 6, 2024

5 min read

Femasys’ FemaSeed FDA Clearance Brings Timely Access to a First-Line Infertility Treatment Option as an Alternative to IVF

February 28, 2024

4 min read

Business

Femasys Inc. Advances Commercial Readiness with Appointment of Richard Spector to New Position of Chief Commercial Officer

February 6, 2024

7 min read

Femasys Inc. Begins FemBloc Pivotal Trial Enrollment at UC Davis Medical Center, a Hub for Innovation and Groundbreaking Research in Health Care for Women

January 26, 2024

7 min read

Femasys Inc. Begins FemBloc Pivotal Trial Enrollment at University of Utah, an Internationally Recognized Center in Obstetrics and Gynecology

January 23, 2024

6 min read

Femasys Inc. Begins FemBloc Pivotal Trial Enrollment at Stanford Medicine

December 15, 2023

7 min read

AWARDS

JOBS